Pharmacology and therapeutics of bronchodilators revisited

MG Matera, CP Page, L Calzetta, P Rogliani… - Pharmacological …, 2020 - ASPET
Bronchodilators remain the cornerstone of the treatment of airway disorders such as asthma
and chronic obstructive pulmonary disease (COPD). There is therefore considerable interest …

[HTML][HTML] The treatment of mild and moderate asthma in adults

M Lommatzsch, R Buhl, S Korn - Deutsches Ärzteblatt International, 2020 - ncbi.nlm.nih.gov
Background Asthma is a chronic inflammatory airway disease that usually causes variable
airway obstruction. It affects 5–10% of the German population. Methods This review is based …

[HTML][HTML] Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K guideline of the German society of allergology and clinical immunology (DGAKI) …

O Pfaar, T Ankermann, M Augustin, P Bubel… - Allergologie …, 2022 - ncbi.nlm.nih.gov
Pneumologists, Sleep and Respiratory Physicians (BdP)(Sebastian Böing), Professional
Association of German Dermatologists (BVDD)(Klaus Strömer) were taking part in the …

[HTML][HTML] Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: position paper of Ärzteverband Deutscher …

L Klimek, O Pfaar, M Worm, T Eiwegger… - Allergologie …, 2020 - ncbi.nlm.nih.gov
Background: Since the beginning of the COVID-19 pandemic, the treatment of patients with
allergic and atopy-associated diseases has faced major challenges. Recommendations for …

S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023

M Lommatzsch, CP Criée, CCM de Jong… - …, 2023 - thieme-connect.com
Das Management von Asthma hat sich in den letzten Jahrzehnten fundamental gewandelt.
Die vorliegende Leitlinie zur Diagnostik und Therapie von Asthma wurde für pneumologisch …

[HTML][HTML] In-patient pulmonary rehabilitation to improve asthma control: a randomized controlled study (EPRA, Effectiveness of Pulmonary Rehabilitation for Patients …

K Schultz, M Wittmann, R Wagner… - Deutsches Ärzteblatt …, 2021 - ncbi.nlm.nih.gov
Background Despite the availability of effective pharmaceutical treatment options, many
patients with asthma do not manage to control their illness. This randomized trial with a …

Respiratory afflictions during hairdressing jobs: case history and clinical evaluation of a large symptomatic case series

J Hiller, A Greiner, H Drexler - Journal of Occupational Medicine and …, 2022 - Springer
Objectives Respiratory symptoms at work are common among hairdressers. Various working
materials, most notably bleaching ingredients such as ammonium persulfate, have been …

Alteration of immunophenotype of human macrophages and monocytes after exposure to cigarette smoke

CO da Silva, T Gicquel, Y Daniel, T Bartholo, E Vene… - Scientific reports, 2020 - nature.com
Cigarette smoke exposure (CS) is the main risk factor for chronic obstructive pulmonary
disease (COPD). Macrophages have an important role in COPD because they release pro …

[HTML][HTML] Biologics for atopic diseases: Indication, side effect management, and new developments

U Jappe, H Beckert, KC Bergmann, A Gülsen… - Allergologie …, 2021 - ncbi.nlm.nih.gov
With the advent of biologicals, more and more therapeutics are available that specifically
address specific switch points in the pathomechanism of immunologically dominated …

[HTML][HTML] Measurement of fractional exhaled nitric oxide: comparison of three different analysers

S Korn, M Wilk, S Voigt, S Weber, T Keller, R Buhl - Respiration, 2020 - karger.com
Background: Fractional exhaled nitric oxide (FeNO) is a surrogate marker for airway
inflammation, supporting the diagnostic pathway and treatment decisions for asthma …